Parkinsonism signs embody a tremor, slowness of motion, and muscle stiffness, with Parkinson’s illness being one of the higher recognized causes. Parkinson’s illness is a progressive neurological situation that impacts greater than 137,000 Britons; every year, there are roughly 17,300 new diagnoses of Parkinson’s in folks aged 45 and above, in keeping with the National Institute for Health and Care Excellence (NICE).
On March 23, 2022, a new research paper steered that “older people taking statin drugs have a lower chance of developing parkinsonism later compared to people who were not taking statins”.
Published within the American Academy of Neurology journal, the research’s lead creator, Dr Shahram Oveisgharan, of Rush University Medical Center in Chicago, commented on the findings.
“Our results suggest people using statins may have a lower risk of parkinsonism and that may be partly caused by the protective effect statins may have on arteries in the brain.
READ MORE: Vaccinated aspiring model, 21, has both legs amputated after traumatic Covid complications
“Our outcomes are thrilling, as a result of motion issues in older adults that come underneath the umbrella of parkinsonism are widespread, usually debilitating and usually untreatable.”
The research details
The study included 2,841 people who averaged around 76 years of age; they did not have parkinsonism at the start of the research.
Of those, 936 people (33 percent) were taking statins, which is mainly prescribed to lower unhealthy cholesterol levels.
Thus, the researchers concluded that people taking statins – after accounting for age, sex, and vascular risks – were 16 percent at lower risk of developing parkinsonism symptoms six years later.
Dr Oveisgharan added: “More research is required, however statins might be a therapeutic possibility sooner or later to assist cut back the consequences of parkinsonism within the common inhabitants of older adults. Not simply folks with excessive ldl cholesterol or who’re in danger for stroke.”
One weakness of the research project was that the parkinsonism evaluations were not conducted by movement disorder specialists.
As such, cases of parkinsonism may have been misclassified, thereby affecting the results.
Regardless, the current use of statins to lower cholesterol levels has been well researched and been shown to be effective.
For example, the cholesterol charity Heart UK pointed out that statins could reduce cholesterol levels by up to 50 percent.